RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitus.

Linagliptin: a novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitus.

Add to Collection
2011 Sep Others SB Ghatak, DS Patel, N Shanker… - Current diabetes …, 2011 - ingentaconnect.com

Full Author : ['Ghatak, Somsuvra B', 'Patel, Devang S', 'Shanker, Neeraj', 'Srivastava, Ambrish', 'Deshpande, Shrikalp S', 'Panchal, Shital J']
Journal Title : Current diabetes reviews
Chapter : Section4, Section5
Journal Year : 2011
Cited by : 12

Type 2 diabetes mellitus causes significant morbidity and mortality on account of its progressive nature and results in considerable burden on healthcare resources. Current treatment strategies have only limited long-term efficacy and tolerability given t..... Read More

Keywords : ['type ii diabetes mellitus', 'novel xanthinebase dipeptidyl inhibitor', 'treatment', 'linagliptin']
PubMed Link : https://www.ingentaconnect.com/content/ben/cdr/2011/00000007/00000005/art00004
Google Scholar Link : https://scholar.google.com/scholar?cites=18316663708263790601&as_sdt=2005&sciodt=0,5&hl=en&num=20